Jenna L Steiner1, Angela M Pierce2, Andrea M Griesinger2, Bethany L Veo2, Aaron Knox2, Nathan Dahl3, Adam Green3, Nicholas K Foreman3, Rajeev Vibhakar3, and Natalie J Serkova1
1Radiology, University of Colorado Denver, Aurora, CO, United States, 2University of Colorado Denver, Aurora, CO, United States, 3Neurooncology, Children's Hospital Colorado, Aurora, CO, United States
Synopsis
Brain tumors are the second most common
malignancy in childhood (exceeded only by leukemia). Clinically,
multiparametric MRI is now considered to be the neuroimaging standard for
detecting brain tumors. Pediatric brain tumors have a diverse array of clinical
manifestations, cellular and molecular phenotypes, and tumor habitats. There is
an unmet need to develop human-faithful pediatric mouse models and fast
high-resolution physiological MRI for their detection and characterization.
Here, we report on a non-gadolinium, Multiparametric Advanced Fast Imaging
(MAFI) approach followed by radiomics analysis to detect, characterize and
differentiate three distinct brain tumor subtypes in mouse patient-derived
xenograft (PDX) models.
Introduction:
Adult
brain tumors vastly outnumber pediatric tumors and are therefore better
studied. Brain tumors in children, as opposed to those in adults, are
characterized by more diverse tumor types, lower incidence, and a
prognosis that at times depends on age 1. Current proven therapies
that are effective in treating a variety of pediatric high grade brain
malignancies include neurosurgery, radiotherapy, and chemotherapy. Multiparametric Magnetic Resonance
Imaging (MRI) remains a gold standard for detection and follow-up of pediatric
brain tumors. The goal of this pre-clinical MRI study was to develop a
Multiparametric Advanced Fast Imaging (MAFI) approach for a rapid and sensitive
localization of intracranial tumors and characterization of tumor “habitat”
including development of angiogenesis, peritumoral edema and metastatic spread.
Mouse patient-derived xenograft (PDX) models for pediatric medulloblastomas
(the most common malignant brain tumor in childhood, 18% of all brain
neoplasms), high-grade gliomas (the second most common, 15%) and ependymoma
(the third most common, 12%), were employed in this study 2,3.Methods:
All animal protocols were reviewed and approved by the University of
Colorado IACUC. Female severely immunodeficient (scid) mice were used for
intracranial orthotopical inoculation of pediatric PDX: medulloblastomas into
the fourth ventricle (n=6); diffuse intrinsic pontine gliomas (DIPG) directly into
the pons (n=6), and ependymomas into the fourth ventricle (n=12). All image acquisition was performed one, three
and over five weeks after inoculation using an ultra-high field Bruker 9.4
Tesla BioSpec MR scanner. A Bruker mouse head array RF cryo-coil was used for
all experiments. Non-gadolinium MAFI protocols were developed based on
high-resolution T2w turboRARE (3D, 5min22s), FLAIR (sagittal, 1min54s), fast
spin echo diffusion weighted imaging (DWI axial, 1min17s) with 6 b-values. Analytical
methodologies included (i) conventional volumetric analysis, blood vessel
density and apparent diffusion coefficient (ADC) values using ParaVision NEO
software, as well as (ii) shape and texture based radiomics descriptors to characterize
tumor habitat of each tumor sub-type using a modified COLIAGE software
4,5Results:
High-resolution
turboRARE T2w-MRI (0.62 microns in-plane resolution) clearly showed that all PDX
were inoculated and homed at the proper anatomical location: the posterior
fossa for medulloblastomas; the pons for PDIG; and the cerebellum for
ependymomas (Figure 1A-C). The sensitivity of T2w-MRI scans was 0.2 mm3
for the smallest tumor detected (Figure 1D). They also revealed increased blood
vessel densities (in the early stage, mean tumor volume 0.2 – 30 mm3),
necrosis and intracranial metastases (the late stage, mean tumor volume >40
mm3) (Figure 2A-C). FLAIR MRI precisely identified peritumoral regions
of the diffuse disease, and together with DWI, of vasogenic edema. The ADC
values were notably low in medulloblastomas (as low as 0.58x10-3
mm/s) (Figure 3A). For radiomics analysis, each scan was segmented into three
regions: (i) well defined tumor (including distant metastases); (ii) peritumoral
edema; (iii) tumor necrosis (Figure 3B). 360 radiomics features (capturing
co-occurrence, grey-level dependence and directional gradients) were obtained
for each region from the MAFI protocol. A subset of twelve tumoral, six
peritumoral and two distant MRI radiomics features were found to be predictive
of the tumor sub-type (p=0.00024) independently of tumor anatomical location
(Figure 3C). Discussion:
Orthotopically implanted PDX xenografts closely
mimic histological features, invasiveness, metastasis and radiological features
of the primary tumors. Applied MAFI MRI protocol followed by radiomics feature
analysis discriminated among specific radiological features for three distinct orthotopic
PDX models: medulloblastomas exhibit higher levels of necrosis, lower ADC
values, and higher angiogenesis as compared to ependymomas (a higher level of
edema and inflammation, spinal metastatic spread) and DIPG (low blood vessel
densities) (Figure 4).
Conclusion:
We
successfully developed a comprehensive MAFI approach and radiomics analysis to
make accurate and rapid detection and characterization of tumor anatomy and
microenvironment in mouse models of pediatric PDX brain tumor models. Radiomics
features from tumor and peritumoral regions capture tumor habitat specific for
each tumor sub-type. Future studies will include injections of iron-oxide based
dynamic susceptibility contrast (DSC-MRI) and quantitative T2/T2* maps for
additional imaging features related to perfusion and inflammation in pediatric
brain tumor models, especially during the course of radiation therapy.Acknowledgements
No acknowledgement found.References
[1] Blumcke I, Spreafico R, et al.: Histopathological
findings in brain tissue obtained during epilepsiy surgery. N Engl J Med 2017, 377: 1648-56
[2] Sanden E, Dyberg C, et al.: Establishment and
characterization of an orthotopic patient-derived group 3 medulloblastoma model
for preclinical drug evaluation. Sci Rep
2017, 7: 46366
[3] Pierce AM, Keating AK: Creating anatomically accurate and
reproducible intracranial xenografts of human brain tumors. J Vis Exp 2014, 24: 52017
[4] Prasanna P, Patel J, Partovu S, Madabhushi A, Tiwari P:
Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric
MR imaging. Eur Radiol 2017, 27:
4188-97
[5] Beig N, Prasanna P, et al.: Radiogenomic analysis of
hypoxia pathway is predictve of overall survival in glioblastoma. Sci Rep 2018, 8: 7.